Copied
 
 
Formål
Formål
Selskabets formål er forskning- og udviklingsaktiviteter inden for lægemiddelindustrien, især indenfor den radiofarmaceutiske industri, samt al virksomhed som efter ledelsens skøn har forbindelse hermed.
Sidst opdateret den 05.02.2021 og angivet som gældende fra 02.02.2021 (1300 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 05.02.2021 og angivet som gældende fra 02.02.2021 (1300 dage).
Ingen historik.
Branche
Branche
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900).
Sidst opdateret den 05.02.2021 og angivet som gældende fra 02.02.2021 (1300 dage).
Ingen historik.
Revision
Revisionfravalgt
false.
Sidst opdateret den 16.02.2023 og angivet som gældende fra 30.12.2022 (604 dage).
HistorikStartStop
false30.12.2022
true02.02.202129.12.2022
Revisor
Revisor
KALLERMANN REVISION A/S STATSAUTORISERET REVISIONSFIRMA
Sidst opdateret den 16.02.2023 og angivet som gældende fra 30.12.2022 (604 dage).
Ingen historik.
Form
Virksomhedsform
80.
Sidst opdateret den 05.02.2021 og angivet som gældende fra 02.02.2021 (1300 dage).
Ingen historik.
Kontakt
Kontaktoplysninger
contact@tetrakit.com.
Sidst opdateret den 30.05.2022 og angivet som gældende fra 30.05.2022 (818 dage).
Ingen historik.
Telefon
Ingen nuværende registrering.
Ingen historik.
Navne
Ingen historik.
Binavne
Binavne
Tetrakit ApS.
Sidst opdateret den 05.02.2021 og angivet som gældende fra 02.02.2021 (1300 dage).
Ingen historik.
Tegningsregel
Tegningsregel
Selskabet tegnes af to bestyrelsesmedlemmer i forening.
Sidst opdateret den 05.02.2021 og angivet som gældende fra 02.02.2021 (1300 dage).
Fortolkning (1 tegningsmulighed)
2 bestyrelsesmedlemmer +
Ingen historik.
Ansatte
25.08.2024
Ingen historik.
Kapital
25.08.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Kallermann Revision A/S - statsautoriseret revisionsfirma
Revisionsvirksomhedens CVR-nr.:30195264
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis of opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibility under those standards and requirements are further described in the “Auditors' responsibility for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (including International Independence Standards) (IESBA Code) together with the ethical requirements that are relevant to our audit of the financial statement in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Opinion We have audited the financial statements of Tetrakit Technologies ApS for the financial year 1 January 2023 - 31 December 2023, which comprise an income statement, balance sheet, statement of changes in equity and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2023 and of the results of its operations for the financial year 1 January 2023 - 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of opinion providing assurance regarding the Management's review. Our responsibility in connection with our audit of the financial statements is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or with the knowledge we have gained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review meets the disclosure requirements in the Danish Financial Statements Act. Based on our procedures, we are of the opinion that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements in the Danish Financial Statements Act. In our opinion, the Management's review is not materially misstated. , Statement on Management's Review Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of opinion providing assurance regarding the Management's review. Our responsibility in connection with our audit of the financial statements is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or with the knowledge we have gained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review meets the disclosure requirements in the Danish Financial Statements Act. Based on our procedures, we are of the opinion that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements in the Danish Financial Statements Act. In our opinion, the Management's review is not materially misstated.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
25.08.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
25.08.2024
Hjemmeside
www.tetrakit.com.
Sidst opdateret den 30.05.2022 og angivet som gældende fra 30.05.2022 (818 dage).
Ingen historik.